| A review on advances in graphene-derivative/polysaccharide bionanocomposites: therapeutics, pharmacogenomics and toxicity P Makvandi, M Ghomi, M Ashrafizadeh, A Tafazoli, T Agarwal, M Delfi, ... Carbohydrate polymers 250, 116952, 2020 | 66 | 2020 |
| Noonan syndrome–a new survey A Tafazoli, P Eshraghi, ZK Koleti, M Abbaszadegan Archives of Medical Science 13 (1), 215-220, 2017 | 64 | 2017 |
| Effects of quercetin on microRNAs: A mechanistic review V Akbari Kordkheyli, A Khonakdar Tarsi, MA Mishan, A Tafazoli, ... Journal of Cell Biochemistry, 2019 | 39 | 2019 |
| Applying next-generation sequencing platforms for pharmacogenomic testing in clinical practice A Tafazoli, HJ Guchelaar, W Miltyk, AJ Kretowski, JJ Swen Frontiers in Pharmacology 12, 693453, 2021 | 38 | 2021 |
| MicroRNAs and target molecules in bladder cancer PK Parizi, F Yarahmadi, HM Tabar, Z Hosseini, A Sarli, N Kia, A Tafazoli, ... Medical Oncology 37, 1-33, 2020 | 31 | 2020 |
| Engineered silver nanoparticles, a new nanoweapon against cancer MA Ebrahimzadeh, A Tafazoli, J Akhtari, P Biparva, S Eslami Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2018 | 27 | 2018 |
| Prevalence of nontuberculous mycobacteria isolated from environmental samples in Iran: A meta-analysis A Khaledi, A Bahador, D Esmaeili, A Tafazoli, K Ghazvini, D Mansury Journal of Research in Medical Sciences 21 (1), 58, 2016 | 22 | 2016 |
| Applying computer simulations in battling with COVID-19, using pre-analyzed molecular and chemical data to face the pandemic MAK Tabari, H Khoshhal, A Tafazoli, M Khandan, A Bagheri Informatics in medicine unlocked 21, 100458, 2020 | 20 | 2020 |
| Novel mutations and their genotype-phenotype correlations in patients with Noonan syndrome, using next-generation sequencing A Tafazoli, P Eshraghi, F Pantaleoni, R Vakili, M Moghaddassian, ... Advances in medical sciences 63 (1), 87-93, 2018 | 20 | 2018 |
| Knowledge and attitude toward genetic diseases and genetic tests among pre-marriage individuals: A cross-sectional study in northern Iran MB Hashemi-Soteh, AV Nejad, G Ataei, A Tafazoli, D Ghasemi, R Siamy International Journal of Reproductive BioMedicine 17 (8), 543, 2019 | 15 | 2019 |
| Combination of genetics and nanotechnology for down syndrome modification: A potential hypothesis and review of the literature A Tafazoli, F Behjati, DD Farhud, MR Abbaszadegan Iranian Journal of Public Health 48 (3), 371, 2019 | 14 | 2019 |
| Development of an extensive workflow for comprehensive clinical pharmacogenomic profiling: lessons from a pilot study on 100 whole exome sequencing data A Tafazoli, M van der Lee, JJ Swen, A Zeller, N Wawrusiewicz-Kurylonek, ... The Pharmacogenomics Journal 22 (5), 276-283, 2022 | 9 | 2022 |
| Strategies to improve the clinical outcomes for direct-to-consumer pharmacogenomic tests A Tafazoli, RK Guggilla, Z Kamel-Koleti, W Miltyk Genes 12 (3), 361, 2021 | 9 | 2021 |
| Haplotypes inside the beta-globin gene: use as new biomarkers for beta-thalassemia prenatal diagnosis in north of Iran MB Hashemi-Soteh, SS Mousavi, A Tafazoli Journal of Biomedical Science 24, 1-5, 2017 | 9 | 2017 |
| Pharmacogenomics, how to deal with different types of variants in next generation sequencing data in the personalized medicine area A Tafazoli, N Wawrusiewicz-Kurylonek, R Posmyk, W Miltyk Journal of Clinical Medicine 10 (1), 34, 2020 | 8 | 2020 |
| Four novel mutations of the BCKDHA, BCKDHB and DBT genes in Iranian patients with maple syrup urine disease M Zeynalzadeh, A Tafazoli, A Aarabi, M Moghaddassian, F Ashrafzadeh, ... Journal of Pediatric Endocrinology and Metabolism 31 (2), 205-212, 2018 | 8 | 2018 |
| Pharmacogenomic biomarkers of follicle-stimulating hormone receptor malfunction in females with impaired ovarian response—a genetic survey A Tafazoli, S Wołczyński, N Wawrusiewicz-Kurylonek, SA Esmaeili, ... Journal of Clinical Medicine 10 (2), 170, 2021 | 5 | 2021 |
| An overview on the effects of silibinin on different microRNAs expression in cancer V Akbari Kordkheyli, E Nabipur, A Tafazoli, A Bagheri Journal of Mazandaran University of Medical Sciences 28 (165), 213-229, 2018 | 5 | 2018 |
| Nanovehicle-based small interfering RNA (siRNA) delivery for therapeutic purposes: a new molecular approach in pharmacogenomics J Akhtari, A Tafazoli, H Mehrad-Majd, A Mahrooz Current Clinical Pharmacology 13 (3), 173-182, 2018 | 5 | 2018 |
| The correlation between phospholipase C epsilon (PLCE1) gene polymorphisms and risk of gastric adenocarcinoma in Iranian population R Shekarriz, S Faghani, A Tafazoli, MB Hashemi-Soteh International Journal of Hematology-Oncology and Stem Cell Research 13 (3), 108, 2019 | 3 | 2019 |
Wojciech MiltykMedical University in Bialystok在 umb.edu.pl 的电子邮件经过验证
